Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

被引：450

作者：

Lennon, Anne Marie ^{[1
,2
,3
]}

Buchanan, Adam H. ^{[4
]}

Kinde, Isaac ^{[5
]}

Warren, Andrew ^{[5
,6
]}

Honushefsky, Ashley ^{[4
]}

Cohain, Ariella T. ^{[5
]}

Ledbetter, David H. ^{[4
]}

Sanfilippo, Fred ^{[7
]}

Sheridan, Kathleen ^{[4
]}

Rosica, Dillenia ^{[4
]}

Adonizio, Christian S. ^{[4
,8
]}

Hwang, Hee Jung ^{[5
]}

Lahouel, Kamel ^{[1
,9
]}

Cohen, Joshua D. ^{[1
,2
,10
,11
,12
]}

Douville, Christopher ^{[1
,11
]}

Patel, Aalpen A. ^{[4
]}

Hagmann, Leonardo N. ^{[5
]}

Rolston, David D. ^{[4
]}

Malani, Nirav ^{[5
]}

Zhou, Shibin ^{[1
,11
]}

Bettegowda, Chetan ^{[1
,11
,13
]}

Diehl, David L. ^{[4
]}

Urban, Bobbi ^{[5
]}

Still, Christopher D. ^{[4
]}

Kann, Lisa ^{[5
]}

Woods, Julie I. ^{[4
]}

Salvati, Zachary M. ^{[4
]}

Vadakara, Joseph ^{[4
]}

Leeming, Rosemary ^{[4
]}

Bhattacharya, Prianka ^{[4
]}

Walter, Carroll ^{[4
]}

Parker, Alex ^{[5
]}

Lengauer, Christoph ^{[5
,6
]}

Klein, Alison ^{[1
,2
,14
]}

Tomasetti, Cristian ^{[1
,9
,15
]}

Fishman, Elliot K. ^{[1
,2
,16
]}

Hruban, Ralph H. ^{[1
,2
,17
]}

Kinzler, Kenneth W. ^{[1
,2
,11
]}

Vogelstein, Bert ^{[1
,2
,10
,11
]}

Papadopoulos, Nickolas ^{[1
,2
,11
,17
]}

机构：

[1] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Canc Ctr, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, 733 N Broadway, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Med, 733 N Broadway, Baltimore, MD 21205 USA

[4] Geisinger, 100 N Acad Ave, Danville, PA 17822 USA

[5] Thrive Earlier Detect Corp, 38 Sidney St, Cambridge, MA 02139 USA

[6] Third Rock Ventures LLC, 29 Newbury St, Boston, MA 02116 USA

[7] Emory Univ, Sch Med, Dept Pathol & Lab Med, 100 Woodruff Circle, Atlanta, GA 30322 USA

[8] Geisinger Canc Inst, 100 N Acad Ave, Danville, PA 17822 USA

[9] Johns Hopkins Univ, Dept Oncol, Sch Med, Div Biostat & Bioinformat, 733 N Broadway, Baltimore, MD 21205 USA

[10] Johns Hopkins Univ, Howard Hughes Med Inst, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA

[11] Johns Hopkins Univ, Ludwig Ctr, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA

[12] Johns Hopkins Univ, Dept Biomed Engn, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA

[13] Johns Hopkins Univ, Dept Neurosurg, Sch Med, 733 N Broadway, Baltimore, MD 21205 USA

[14] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA

[15] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA

[16] Johns Hopkins Univ, Sch Med, Dept Radiol, 733 N Broadway, Baltimore, MD 21205 USA

[17] Johns Hopkins Univ, Sch Med, Dept Pathol, 733 N Broadway, Baltimore, MD 21205 USA

来源：

SCIENCE | 2020年 / 369卷 / 6499期

基金：

美国国家卫生研究院;

关键词：

DNA; PLASMA; QUANTIFICATION; STRATEGIES; MUTATIONS; DIAGNOSIS;

D O I：

10.1126/science.abb9601

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cancer treatments are often more successful when the disease is detected early. We evaluated the feasibility and safety of multicancer blood testing coupled with positron emission tomographycomputed tomography (PET-CT) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously known to have cancer. Positive blood tests were independently confirmed by a diagnostic PET-CT, which also localized the cancer. Twenty-six cancers were detected by blood testing. Of these, 15 underwent PET-CT imaging and nine (60%) were surgically excised. Twenty-four additional cancers were detected by standard-of-care screening and 46 by neither approach. One percent of participants underwent PET-CT imaging based on false-positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated into routine clinical care, in some cases leading to surgery with intent to cure.

引用

页码：49 / +

页数：40

共 65 条

[1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].

Aberle, Denise R. ;

Adams, Amanda M. ;

Berg, Christine D. ;

Black, William C. ;

Clapp, Jonathan D. ;

Fagerstrom, Richard M. ;

Gareen, Ilana F. ;

Gatsonis, Constantine ;

Marcus, Pamela M. ;

Sicks, JoRean D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409

[2] Universal cancer screening: revolutionary, rational, and realizable [J].

Ahlquist, David A. .

NPJ PRECISION ONCOLOGY, 2018, 2

[3] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].

Amin, Mahul B. ;

Greene, Frederick L. ;

Edge, Stephen B. ;

Compton, Carolyn C. ;

Gershenwald, Jeffrey E. ;

Brookland, Robert K. ;

Meyer, Laura ;

Gress, Donna M. ;

Byrd, David R. ;

Winchester, David P. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99

[4] Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study [J].

Andre, Thierry ;

de Gramont, Armand ;

Vernerey, Dewi ;

Chibaudel, Benoist ;

Bonnetain, Franck ;

Tijeras-Raballand, Annemilai ;

Scriva, Aurelie ;

Hickish, Tamas ;

Tabernero, Josep ;

Van Laethem, Jean Luc ;

Banzi, Maria ;

Maartense, Eduard ;

Shmueli, Einat ;

Carlsson, Goran U. ;

Scheithauer, Werner ;

Papamichael, Demetris ;

Moeehler, Marcus ;

Landolfi, Stefania ;

Demetter, Pieter ;

Colote, Soudhir ;

Tournigand, Christophe ;

Louvet, Christophe ;

Duval, Alex ;

Flejou, Jean-Francois ;

de Gramont, Aimery .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) :4176-+

[5]

[Anonymous], 2018, Behavioral risk factor surveillance system survey data

[6]

[Anonymous], 2020, CANC DISCOV, DOI DOI 10.1111/CAS.14494

[7] The emerging clinical relevance of genomics in cancer medicine [J].

Berger, Michael F. ;

Mardis, Elaine R. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (06) :353-365

[8] Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].

Bettegowda, Chetan ;

Sausen, Mark ;

Leary, Rebecca J. ;

Kinde, Isaac ;

Wang, Yuxuan ;

Agrawal, Nishant ;

Bartlett, Bjarne R. ;

Wang, Hao ;

Luber, Brandon ;

Alani, Rhoda M. ;

Antonarakis, Emmanuel S. ;

Azad, Nilofer S. ;

Bardelli, Alberto ;

Brem, Henry ;

Cameron, John L. ;

Lee, Clarence C. ;

Fecher, Leslie A. ;

Gallia, Gary L. ;

Gibbs, Peter ;

Le, Dung ;

Giuntoli, Robert L. ;

Goggins, Michael ;

Hogarty, Michael D. ;

Holdhoff, Matthias ;

Hong, Seung-Mo ;

Jiao, Yuchen ;

Juhl, Hartmut H. ;

Kim, Jenny J. ;

Siravegna, Giulia ;

Laheru, Daniel A. ;

Lauricella, Calogero ;

Lim, Michael ;

Lipson, Evan J. ;

Marie, Suely Kazue Nagahashi ;

Netto, George J. ;

Oliner, Kelly S. ;

Olivi, Alessandro ;

Olsson, Louise ;

Riggins, Gregory J. ;

Sartore-Bianchi, Andrea ;

Schmidt, Kerstin ;

Shih, Ie-Ming ;

Oba-Shinjo, Sueli Mieko ;

Siena, Salvatore ;

Theodorescu, Dan ;

Tie, Jeanne ;

Harkins, Timothy T. ;

Veronese, Silvio ;

Wang, Tian-Li ;

Weingart, Jon D. .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[9] Validation of a decision regret scale [J].

Brehaut, JC ;

O'Connor, AM ;

Wood, TJ ;

Hack, TF ;

Siminoff, L ;

Gordon, E ;

Feldman-Stewart, D .

MEDICAL DECISION MAKING, 2003, 23 (04) :281-292

[10] Survival of patients with symptom- and screening-detected colorectal cancer [J].

Brenner, Hermann ;

Jansen, Lina ;

Ulrich, Alexis ;

Chang-Claude, Jenny ;

Hoffmeister, Michael .

ONCOTARGET, 2016, 7 (28) :44695-44704

← 1 2 3 4 5 6 7 →